Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced that Arthur Sands, M.D., Ph.D., chief...
-
SAN FRANCISCO, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s natural process to control protein levels, today announced Lori A....
-
FOSTER CITY, Calif. and SAN FRANCISCO, June 19, 2019 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s...
-
SAN FRANCISCO, April 04, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced...
-
Nurix Therapeutics to Present at 2019 American Association for Cancer Research (AACR) Annual Meeting
SAN FRANCISCO, March 19, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced an...
-
SAN FRANCISCO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
-
SAN FRANCISCO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
-
SAN FRANCISCO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
-
SAN FRANCISCO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, today announced that...
-
SAN FRANCISCO, May 08, 2018 (GLOBE NEWSWIRE) -- Nurix, Inc., a private drug discovery company, today announced the appointment of Dr. Nancy Pryer as the company’s chief development officer. Dr....